|
|
||
Ranitidine |
|||
|
|
|||
|
|||
|
|
|||
|   | |||
|
|
|||
|
|
Avoid contact with spores from rotting vegetation e.g. compost, leafmould Mowing the lawn may disturb pollen and spores If you are considering air conditioning for your house, investigate before you buy. It can be expensive and not all types are suitable Vacuum filters need to be effective against the extremely small pollen and fungal spores. The type of filter required is a HEPA. This is a type, not a brand name. About 2 years ago, i couldn't seem to keep up with anything anymore-moving in slow motion it seemed. Severe pain ; , ranitidine used to treat ulcers and gastroesophageal reflux disease GERD , rifampin used to treat tuberculosis ; . Keep a list of all the medicines you take and tell your doctor and pharmacist about every medication you take. This means both prescription medications the ones your doctor writes for you ; and over-the-counter medications the ones you buy in the drugstore, like cold or allergy medicines ; , or natural health products herbal medicines ; . PROPER USE OF THIS MEDICATION Usual dose: Your doctor will tell you how many AVANDAMET tablets to take and how often. This should also be printed on the label of your prescription. AVANDAMET should be taken by mouth and with meals. Your doctor may need to adjust your dose until your blood sugar is better controlled. Test your blood sugar regularly as your doctor tells you. Remember: this medicine has been prescribed only for you. Do not give it to anybody else. Overdose: Taking too much of any medicine can be dangerous. If you take too many AVANDAMET tablets at once, call your doctor or go to the emergency room of your local hospital. Missed Dose: Take one dose as soon as you remember. Then take the next dose at the usual time. Never take extra doses in one day to make up for a missed dose the day before. If you miss a whole day of AVANDAMET, just take your dose as usual the next day. Don't try to make it up by taking extra tablets. Recommended clinical and laboratory tests while taking AVANDAMET: Your doctor may do additional blood sugar tests to see how well AVANDAMET is working. Your doctor may conduct various blood or laboratory tests to monitor your health and liver before you start AVANDAMET and repeat the tests periodically while you are on AVANDAMET. Your doctor should check your eyes regularly. Rarely, some patients have experienced vision changes due to swelling in the back of the eye while taking AVANDAMET! Musculoskeletal conditions Skelaxin is indicated for spasms of the larger muscles of the body and would not primarily be used for a hand injury. Rannitidine is a competitive, reversible inhibitor of the action of histamine and the histamine H2 receptor. Rajitidine is indicated in treatment of duodenal and gastric ulcers, erosive esophagutis and gastric hypersecretory conditions . Naproxen and other non-steroidal anti-inflammatory medications can cause irritation and bleeding to the gastric lining. This is not a secretory phenomenon and therefore ranitidine would provide no benefit or protection to Naproxen-induced gastric irritation. Petitioner timely appealed the denial. B. Legal Standards. TOTAL NUMBER OF PATIENTS : 335 100.0% PATIENTS WITH MEDICATIONS : 269 80.3% CLASSIFICATION LEVEL 1 : GENERIC TERM N % 1 0.3 KAOLIN 3 0.9 LACTULOSE 1 0.3 LOPERAMIDE 1 0.3 LOPERAMIDE HYDROCHLORIDE 8 2.4 MAGNESIUM HYDROXIDE 12 3.6 MAGNESIUM NOS 1 0.3 METHYLCELLULOSE 1 0.3 MINERALS NOS 1 0.3 NATURAL FIBER LAXATIVE 1 0.3 NEOMYCIN 1 0.3 NICOTINAMIDE 1 0.3 NIZATIDINE 1 0.3 OPIUM 1 0.3 OPIUM TINCTURE, BENZOATED 1 0.3 PANCRELIPASE 1 0.3 PARAFFIN, LIQUID 1 0.3 PECTIN 3 0.9 PHOSPHORIC ACID 2 0.6 PSYLLIUM HYDROPHILIC MUCILLOID 1 0.3 PYRIDOXINE HYDROCHLORIDE 1 0.3 RANITIDINE HYDROCHLORIDE 3 0.9 RIBOFLAVIN 1 0.3 SENNA FRUIT 1 0.3 THIAMINE HYDROCHLORIDE 1 0.3 TILACTASE 1 0.3 TRIAMCINOLONE ACETONIDE 3 0.9 VITAMINS NOS 22 6.6 ZINC 2 0.6 NOTE: Concomitant medications refer to all those started on or after baseline or are on-going at baseline and who started before the last date of study medication. He is actually healthier now that he has control of his life back and prevacid. A few years later when i went off the shot my dr. November 2, 2QUl Page 7 rug. Signi~~ant examples include cefadroxil, ranitidine hydrochloride and prazosi hydrochloride. n that made many of A decadeago, ristol-Myers Squi ""BMS" ; submitted a eiti monohydrate capsules, same ~g~ents PI31is currently advocating. BMS marketed ce A for a generic version an antibiotic drug product. Zenith Laboratories CYZenith" ; filed an of the drug. A monograph for the bulk cefadroxil monohydrate mandated a moisture content for the drug substanceof between 4.2 and 6.0 percent. BecauseZenith' active ingredient was a s ~` hemihydrate" form of the drug substance, I3MS argued that Zenith' drug did not conform to s the monograph' moisture content, which was drafted when BMS' monohydrate version was s s the only available form of the drug. In its citizen petition, BMS assertedthat FDA s Id deny approval of the abbreviated antibiotic drug application submitted by Zenith because drug was BMS Citizen Petition, ated July 13, f 990 F not ` same"as the reference listed drug. &the Docket No. 90P-0240 ; . As in the present situation, Zenith developed the hemihydrate form in order to cefadroxil while simult~eously avoiding unhinging on a BMS patent that clai monohydrate. BecauseZenith' product did not infringe BMS' patent, BMS s s generic competition. the ~tibioti~ monograph to accomplish what its patent could not inge GSK' patent, s Simil~ly~ when faced with the reality that Ranbaxy' product does s s PDI seeksto delay FDA' approval of generic cefuroxime axetil tablets by opposing that proval in a citizen petition. FDA ultimately saw through BMS' unfounded allegation and denied s DA Docket No. 90P-0240 Apr. 6, 1992 ; . In reaching its decision, the Agency determined that the anhydrous form of an active ingredient constitutes the ` "Same7active ingredient as the hydrated form, but in a different physical form. In so doing, FDA explained that its respect to the therapeutic equivalence of ingredients with diRerent of hydrati long-st~di~g one, dating back at least to 1976 citing 41 Fed. Reg 7 1976 ; and 44 Fed. Reg. 2950 1979 . A also stated that it had authority to approve an abbreviatedapplication if e product met all of standardsof the antibiotic monograph except for moisture content speci product was bioequivalent to the listed drug just as Ranbaxy' product is bioequivalent to s Ceftin ; . FDA ultimately approved the generic cefadroxil product with labeling that replaced the listed drug' referencesto "cefadroxil monohydrate"with referen s The agency subsequentlyrevised the antibiotic monograph to incl strength, quality and purity of cefadroxil hemihydrate, and the cefadroxil monohydrate and cefadroxil hemihydrate products remained equivalent to and substitutable for one another. PDI, due to its commercial association with GSK, should be well aware of the F position that an active ingredient can be the same even when it arises in istin&ve ~~stalline forms. In November 1994, FDA tentatively approved an A' NDA containing a Form 1 crystalline and zyloprim. Auditor's Report: The following is an excerpt from the Report of Independent Auditors, Stonefield Josephson, Inc., as it appeared in Co.'s 2007 Annual Report: `In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of BSML, Inc. as of December 29, 2007, and December 30, 2006, and the results of its operations and its cash flows for each of the three years in the period ended December 29, 2007, December 30, 2006 and December 31, 2005 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein. The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has yet to achieve profitability and had an accumulated deficit of 6, 623, 000 and a working capital deficiency of , 957, 000 as of December 29, 2007 and incurred a net loss from continuing operations and net cash used by operating activities of , 365, 000 and , 826, 000, respectively, for the fiscal year ended December 29, 2007. The foregoing matters raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.`. The medication guide will also inform patients of the need to discuss with their doctor the risks and benefits of using nsaids and the importance of using the lowest effective dose for the shortest duration possible if treatment with an nsaid is warranted for an individual patient and proventil. Lower airway reactions due to ranitidine without cutaneous symptoms. A 60-year-old man, diagnosed of gastroesophageal reflux, presented sneezes, rhinorrhea, nasal itching, cough, chest tightness and dyspnea after receiving the fourth dose of ranitidine Zantac, GlaxoSmithKline, Madrid, Spain ; 150mg 2 x daily. This treatment was interrupted and the symptoms responded promptly to parenteral steroids. No urticaria or angioedema was observed. He had previously taken ranitidine two years ago without any reaction. He had no other drug allergy and did not have respiratory antecedents or previous episodes of asthma. Skin prick tests were performed with common airborne, latex, Anisakis simplex 1 mg ml ; , and a common food battery IPI, Madrid, Spain and Leti, Barcelona, Spain ; . They were all negative with a normal response to the histamine control. Skin prick-test with ranitidine 10 mg ml ; was performed and proved negative. The intradermal tests with ranitidine were negative with dilutions 1: 100 and 1: 10, as well as famotidine 1% ; . Pulmonary function testing with spirometry and. What is ranitidine medication side effects
1 Figure S10 H NMR spectra of ranitidine pD 1.5 ; at 50 C after a ; 0 days, b ; 2 days, c ; 4 days, d ; 6 days, e ; 10 days, and f ; 13 days. S8. Consult with your veterinarian regarding physical examinations and laboratory testing necessary prior to and during treatment with ranitidine. Drug, Food and Test Interactions Consult your veterinarian before using ranitidine with any other medications, including vitamins and supplements, since interactions may occur. Ranitidinee may decrease white blood cell counts, especially if given with other bone marrow suppressing drugs such as azathioprine. If used with antacids, propantheline bromide, or ketoconazole, give the ranitidine 2 hours before or 2 hours after the other medication s ; . Raniyidine may cause increases in liver enzymes, and possible liver damage. May cause a falsely positive laboratory test for protein in the urine. Signs of Toxicity Overdose Toxicities are rare. May see vomiting, diarrhea, irregular heartbeat, muscle tremors, and rapid breathing. If you know or suspect your pet has had an overdose, or if you observe any of these signs in your pet, contact your veterinarian immediately. Keep this and all other medications out of the reach of children and pets and ventolin. Nonsteroidal anti-inflammatory drugs NSAIDs ; are the basis for the treatment of joint inflammation and their extensive use reflects the significant incidence of rheumatic disease in the general population. NSAIDs are increasingly being used also for non-rheumatic conditions, including acute painful soft tissue musculoskeletal disorders. Although there is no doubt regarding the efficacy and usefulness of NSAIDs, the price paid for their use can be quite high as they can cause severe gastrointestinal effects. The risk of hospitalisation correlated to NSAID therapy is estimated to be 1.3 to 1.6% for regular users of this class of drugs. This represents a significant burden for public health, and also from an economic point of view, FOCUS as seen in a recent study The price paid for oral conducted in the UK, where NSAIDs use can be quite high in terms of the prescriptions for severe NSAIDs, predominantly gastrointestinal oral, reach 20 to 24 million effects each year 5 ; . One interesting alternative is the use of topically applied NSAIDs that can be considered an important therapeutic option in acute soft tissue musculoskeletal disorders. Topical NSAIDs have been shown to cause fewer adverse reactions, particularly systemic events, compared with antiinflammatory analgesic oral formulations of the same dose 6 ; . In agreement with the dictum in medicine primum non nocere first do no harm ; topical NSAIDs may be, in some cases, an alternative therapy in minor acute disorders management. In addition, topical NSAIDs may be useful in chronic arthropathies, where painful. Both ranitidine groups, but the number of acid reflux events after 90 min was reduced by half in the im group. Similarly the mean pH values during these episodes remained somewhat higher than in the iv group. The sum of refluxes was the lowest in the im group. Oesophageal acid clearing was more efficient in this group as the duration of the reflux episodes decreased while the total number of long lasting reflux events five minutes ; was similar to the fv group. Some GOR is physiological in normal healthy persons. These episodes are asymptomatic and characterized by their short duration with rapid elimination of refluxed gastric acid fluid from the oesophagus.22 It is also commonly agreed that the barrier pressure difference between gastric and lower oesophageal sphincter pressures ; is the and flonase. Mastocytosis is the general term for a variety of rare disorders in which there is a proliferation of mast cells in the skin, GI tract, or throughout the entire body. No matter what type of Mastocytosis you have, the goal of treatment is to provide patient relief by either preventing the degranulation of those mast cells, or by blocking the effects of mast cell degranulation. Degranulation, or the rupturing of mast cells, releases histamine, leukotrienes, prostaglandin D2 and other mast cell mediators into the body, causing the symptoms common with Mastocytosis. Degranulation can be triggered by a wide variety of things such as temperature changes and extremes, stress, alcohol, and various drugs. It is the responsibility of the individual patient to be aware of all the things in their environment that cause them problems. Once Mastocytosis is diagnosed, the physician may recommend treatment based on trial and error, with the goal of finding the right combination of drugs for the individual patient. Some of the most common treatments include: 1. H 1 antihistamines such as chlorpheniramine maleate found in many over-the-counter cold medications ; , and cyproheptadine hydrochloride Periactin ; , help with symptoms such as pruritus itching ; , dermatographism, urticaria pigmentosa, and are often used in conjunction with epinephrine after particularly strong Mastocytosis attacks. Doxepin hydrochloride Sinequan ; , although officially classified as a tricyclic antidepressant, has a very powerful antihistamine effect and is frequently prescribed to control resistant symptoms. Antihistamines appear to compete with histamine for receptor sites on effector cells. If a cell receptor site is occupied by an antihistamine, the body can't chemically interact with histamine, and therefore the chemical cycle is broken before the histamine can work to create a symptom. Nonsedating antihistamines, such as Hismanal astemizole ; and Claritin loratadine ; , may also be helpful. 2. H 2 antihistamines such as ranitidine hydrochloride Zantac ; , Famotidine Pepcid ; , or cimetidine hydrochloride Tagamet ; , treat pathological gastric hypersecretory conditions. They tie up different receptor sites than H1 antihistamines, called H2 receptors. 3. The most valuable drug for the emergency treatment of severe Mastocytosis symptoms is epinephrine. The vasoconstrictor effect of epinephrine directly counteracts the vasodilatation produced by histamine. Epinephrine quickly restores circulating blood volume and blood pressure, and quickly eliminates itching and swelling. Many Mastocytosis patients carry "bee sting kits" so they can inject epinephrine at the onset of a Mastocytosis attack, or use an epinephrine inhaler, which is good for laryngeal swelling and systemic symptoms. The inhalers should be used only under a doctor's orders, as all doctors do not advise its use. Alcohol can be a problem for some patients. If alcohol is a Masto trigger for you, be aware that there are no alcohol-free inhalers. 4. Cromolyn sodium Gastrocrom Oral Concentrate ; is the only drug made specifically for Mastocytosis patients. It helps stabilize mast cells, and if mast cells don't degranulate and release their mediators, they are less likely to cause problems. 5. Nonsteroidal anti-inflammatory agents such as aspirin and similar NSAIDs are often used to directly inhibit the synthesis of prostaglandin D2 PGD2 ; . Steroidal anti-inflammatory agents such as prednisone don't inhibit PGD2 directly; rather they prevent PGD2 formation by blocking phospholipase A2, turning off the whole cascade of arachidonic acid metabolism. Prostaglandins, which are also released when mast cells degranulate, influence blood flow and gastrointestinal function and activity. While some Masto patients take as many as 30 aspirin a day, or very high doses of H2 antihistamines, NSAID doses should be carefully controlled by your physician. 6. Interferon, a protein released by. We examined the distribution of risk factors according to nsaid exposure after age-standardizing the proportions exposed in 10-year age groups to the age distribution of the entire cohort table 2 and decadron. THE EFFECTS OF RANITIDINE, OMEPRAZOLE AND PLACEBO ON INTRA OPERATIVE GASTRO-OESOPHAGEAL REFLUX IN PATIENTS WITH SYMPTOMS OF REFLUX AUTHORS: S. C. Minogue, T. Corcoran, R. Fanning, G. Shorten AFFILIATION: Dept. of Anaesthesia and Intensive care medicine, Cork University Hospital, Cork, Ireland. INTRODUCTION: Pulmonary aspiration is a rare but devestating complication of general anaesthesia.The mortality associated with this event has been reported as being over 60% for severe cases1. Due to an awareness of the problem and changes in clinical practice intended to prevent it, the incidence has decreased dramatically.One factor likely to contribute to the incidence of aspiration is the presence of Gastroesophageal reflux disorder.Five to ten percent of the adult population suffer from GERD2.The presence of "heartburn" and acid regurgitation is predictive of GERD and thus puts the patient at increased risk for perioperative reflux of gastric content3.Agents which alter the volume and acidity of gastric contents may decrease the likelihood of adverse outcome associated with this condition.The aim of this study is to compare the effects of ranitidine and omeprazole on intra-operative reflux in patients symptomatic for GERD undergoing elective surgery. METHODS: With IRB approval and informed patient consent, thirty ASA I and II adult patients describing specific symptoms of GERD and undergoing elective surgery were enrolled and then randomly allocated to recieve placebo, ranitidine or omeprazole as a premedicant. Following administration of a standard general anaesthetic, a pH probe was introduced into the esophagus, esophageal pH monitored and episodes of reflux defined by an abrupt decrease in the pH to a value of 4 ; measured and recorded using a Synectics digitrapper atistical analysis was performed using unpaired one tail t- tests and Chi squared tests as appropriate.P 0.05 was taken to indicate significance. RESULTS: The groups were simliar in terms of age, weight, height and Body Mass Index.as was the symptom score between the two groups. The number of acid refluxes hour in the placebo group was significantly greater then in the ranitidine group and just outside the level of significance when compared to omeprazole.There was no difference in the number of acid refluxes hr. between ranitidine and and omeprazole. The "mean pH 4" was significantly different when comparing placebo to omeprazole and just outside the level of significance comparing placebo to ranitidine. Again there was no significant difference between "mean pH 4" for omeprazole compared to ranitidine. CONCLUSIONS: The most important finding of our study is that the preoperative administration of ranitidine and omeprazole decreases the incidence and duration of acid regurgitation in patients undergoing general anaesthetics and that there is no difference in the incidence of regurgitation in the group recieving omeprazole as a premedication compared to the group receiving ranitidine.These data support the routine preoperative administration of these agents to patients with symptoms suggestive of GERD. REFERENCES: 1. Arch Surg 1973; 106: 49-52 Scand. J Gastroent. Supp. 1995; 211: 5-6 Lancet 1990; 335: 205-9. In two U.S., multicenter double-blind, ranitidine-controlled studies of 925 total patients with frequent GERD symptoms, but no esophageal erosions by endoscopy, lansoprazole 15 mg was superior to ranitidine 150 mg b.i.d. ; in decreasing the frequency and severity of day and night heartburn associated with GERD for the 8-week treatment period. No significant additional benefit from lansoprazole 30 mg once daily was observed. Erosive Esophagitis In a U.S. multicenter, double-blind, placebo-controlled study of 269 patients entering with an endoscopic diagnosis of esophagitis with mucosal grading of 2 or more and grades 3 and 4 signifying erosive disease, the percentages of patients with healing are presented in Table 13: Table 13: Erosive Esophagitis Healing Rates PREVACID 15 mg daily 30 mg daily 60 mg daily N 69 ; N 67.6% 81.3% 80.6% * 87.7% * 95.4% * 94.3% * 90.9% * 95.4% * 94.4% * Placebo N 63 ; 32.8% 52.5 and rhinocort and Buy cheap ranitidine online. References: 1. Judicious Use of Antibiotics for Acute Otitis Media by Kim Palacioz, Pharm.D., Pharmacists Letter, Detail-Document #190701, July 2003. Ranitidine eye dropsThere have been no formal interaction studies for AVANDAMET. The following statements reflect the information available on the individual components rosiglitazone and metformin ; . Co-administration of rosiglitazone with gemfibrozil an inhibitor of CYP2C8 ; resulted in increased rosiglitazone plasma concentrations see Pharmacokinetics ; . Since there is a potential for an increase in the risk of dose-related adverse events, a decrease in rosiglitazone dose may be needed. Co-administration of rosiglitazone and rifampicin an inducer of CYP2C8 ; resulted in decreased rosiglitazone plasma concentrations see Pharmacokinetics ; . Therefore, close monitoring of glycaemic control and changes in diabetic treatment should be considered. Concomitant administration with other oral antidiabetic agents including metformin, glibenclamide and acarbose did not result in any clinically significant pharmacokinetic or pharmacodynamic interactions with rosiglitazone. Rosiglitazone had no effects on the steady state pharmacokinetics of digoxin or warfarin nor did it affect the anti-coagulant activity of warfarin. Pre-treatment with ranitidine did not alter the pharmacokinetics of single oral or intravenous doses of rosiglitazone, suggesting that absorption of oral rosiglitazone is not altered by increases in gastrointestinal pH. In vitro studies demonstrate that rosiglitazone is predominantly metabolised by CYP2C8, with CYP2C9 as only a minor pathway. In addition, clinical data have shown that rosiglitazone had no clinically relevant effect on the pharmacokinetics of S - ; -warfarin a substrate for CYP2C9 ; . Rosiglitazone caused a moderate inhibition of CYP2C8 and a minor inhibition of CYP2C9 in vitro. Significant inhibition of these enzymes is unlikely to occur at therapeutic doses see Pharmacokinetics section ; . Since there are only a few known substrates for CYP2C8 paclitaxel, cerivastatin ; , the potential for an interaction involving this enzyme is even more unlikely. No clinically relevant effects on nifedipine or oral contraceptives components ethinyloestradiol and norethisterone ; were observed after co-administration with rosiglitazone confirming a low probability of interaction with drugs metabolised by CYP3A4. There is an increased risk of lactic acidosis in acute alcohol intoxication due to the metformin component of AVANDAMET see Precautions ; . Iodinated contrast media: Metformin should be temporarily withheld in patients undergoing radiological studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. Symptom relief Lansoprazole was superior to ranitidine in the relief of heartburn and in reducing antacid use p 0.05 in both cases ; . Sontag et al., 199744 n 159 erosive GORD refractory to H2RA therapy Multicentre, randomised, double blind 75 43 84. I so pleased with everyone's Hebrew progress this year. Visits to the class websites have also increased throughout the year. If any of you have not checked out the website for your class yet, it is not too late. There are links to interesting Hebrew sites with games you can play at home as well as activities to help you make really great grades on my tests. Once again, here are the website addresses: Kitah Bet : : quia pages cjdsbet Kitah Gimel: : quia pages cjdsgimel Kitah Dalet: : quia pages cjdsdalet Kitah Heh: : quia pages cjdshebrewheh The websites are updated weekly. Happy Pesach! All the best, Morah Donna. What is the drug ranitidine forRanitidinee, ranifidine, ganitidine, ran9tidine, ranitiidne, rsnitidine, ranittidine, ranitidinf, raitidine, danitidine, ranitidlne, anitidine, ranitidije, rantiidine, ranitidind, rani5idine, ranitid8ne, fanitidine, raniridine, ranitodine, rxnitidine, ranitidie, ranit8dine, 5anitidine, raanitidine, ranitidinne, ranitidihe, rabitidine, 4anitidine, rznitidine, ranitidin3, ranitidinw, ranitidin, ranitirine, ranitidne, rannitidine, ramitidine, ranitudine, ranitiine, ranitiddine, rwnitidine, ranktidine, rnitidine, ranitidime, eanitidine.Ranitidine erectile dysfunctionWhat is ranitidine medication side effects, ranitidine eye drops, what is the drug ranitidine for, ranitidine erectile dysfunction and uses of ranitidine iv. Ranitidine reflux infant, ranitidine equine, drug ranitidine side effects and is it safe to take ranitidine during pregnancy or ranitidine recall. Uses of ranitidine ivSalaam ishq, tetralogy of fallot animation, approval addiction joyce meyer, fasting vegetables and beta cell encapsulation. Deuterium 1934 nobel prize, developmental delay of infant, shrna egfp and function of compound microscope specimen or collagen 3d structure. |
||
|
|
Copyright © 2009 by On-line.blackapplehost.com Inc. | ||